国邦医药
(605507)
| 流通市值：49.06亿 | | | 总市值：90.86亿 |
| 流通股本：3.02亿 | | | 总股本：5.59亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,038,939,796.1 | 2,094,158,957.59 | 2,116,264,964.3 | 2,097,208,714.84 |
| 应收票据及应收账款 | 623,314,494.42 | 532,156,693.33 | 644,835,121.74 | 741,718,276.16 |
| 应收账款 | 623,314,494.42 | 532,156,693.33 | 644,835,121.74 | 741,718,276.16 |
| 应收款项融资 | 364,086,112.08 | 432,764,570.09 | 255,309,928.86 | 122,187,556.51 |
| 预付款项 | 533,332,834.84 | 476,671,799.48 | 456,991,685.55 | 361,144,614.99 |
| 其他应收款合计 | 18,685,330.74 | 17,215,372.28 | 22,167,112.65 | 19,940,520.03 |
| 存货 | 1,463,145,984.74 | 1,368,556,845.48 | 1,336,094,047.83 | 1,381,166,469.29 |
| 其他流动资产 | 21,507,951.9 | 40,043,714.88 | 10,356,118.34 | 30,917,559.7 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,420,999,260.3 | 5,443,146,893.29 | 5,129,609,663.62 | 5,144,733,812.55 |
| 非流动资产: | | | | |
| 长期股权投资 | 100,431,494.29 | 101,126,769.04 | 99,836,448.86 | 101,079,865.3 |
| 其他非流动金融资产 | 20,000,000 | 20,000,000 | - | 10,000,000 |
| 投资性房地产 | 74,525,590.83 | 75,501,908.61 | 76,478,226.39 | 77,454,544.17 |
| 固定资产 | 3,707,286,342.26 | 3,693,392,649.45 | 2,647,407,785.16 | 2,598,974,609.07 |
| 在建工程 | 676,127,402.21 | 636,651,613.98 | 1,428,977,341.13 | 1,303,531,225.37 |
| 无形资产 | 356,238,169.52 | 358,847,188.24 | 362,022,965.34 | 365,005,786.35 |
| 商誉 | 25,487.37 | 25,487.37 | 25,487.37 | 25,487.37 |
| 长期待摊费用 | 7,680,858.65 | 8,023,413.97 | 9,737,537.63 | 8,606,798.89 |
| 递延所得税资产 | 16,964,866.31 | 7,778,437.58 | 14,369,059.8 | 5,830,062.91 |
| 其他非流动资产 | 20,483,139 | 17,140,987.39 | 10,941,397.67 | 35,709,937.45 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,979,763,350.44 | 4,918,488,455.63 | 4,649,796,249.35 | 4,506,218,316.88 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,400,762,610.74 | 10,361,635,348.92 | 9,779,405,912.97 | 9,650,952,129.43 |
| 流动负债: | | | | |
| 短期借款 | 458,169,408.34 | 482,694,130.56 | 501,220,241.67 | 523,450,388.89 |
| 交易性金融负债 | 359,548.73 | - | - | 944,986.3 |
| 应付票据及应付账款 | 1,507,058,205.13 | 1,714,611,824.08 | 1,343,338,800.9 | 1,338,856,198.55 |
| 其中：应付票据 | 886,450,888.97 | 1,090,789,223.93 | 841,458,568.38 | 776,671,539.88 |
| 应付账款 | 620,607,316.16 | 623,822,600.15 | 501,880,232.52 | 562,184,658.67 |
| 合同负债 | 54,650,607.27 | 55,848,631.5 | 38,230,157.46 | 45,231,094.75 |
| 应付职工薪酬 | 50,157,760.57 | 82,517,420.72 | 89,808,480.46 | 77,825,561.79 |
| 应交税费 | 30,185,239.97 | 34,227,177.88 | 19,598,898.85 | 17,724,319.09 |
| 其他应付款合计 | 41,273,029.45 | 46,219,474.34 | 61,205,516.01 | 61,059,834.52 |
| 应付股利 | 621,951.39 | 621,951.39 | 621,951.39 | 621,951.39 |
| 一年内到期的非流动负债 | 28,875,166.67 | 28,875,166.67 | - | - |
| 其他流动负债 | 4,274,688.97 | 4,627,905.23 | 3,154,424.52 | 3,869,631.77 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,175,003,655.1 | 2,449,621,730.98 | 2,056,556,519.87 | 2,068,962,015.66 |
| 非流动负债: | | | | |
| 长期借款 | 584,806,944.43 | 451,700,000 | 381,998,916.67 | 381,972,666.67 |
| 递延收益 | 11,191,855.8 | 11,799,963.18 | 12,411,910.37 | 13,128,028.19 |
| 递延所得税负债 | 21,048,596.01 | 11,324,865.41 | 21,471,858.86 | 10,722,088.17 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 617,047,396.24 | 474,824,828.59 | 415,882,685.9 | 405,822,783.03 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,792,051,051.34 | 2,924,446,559.57 | 2,472,439,205.77 | 2,474,784,798.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 558,823,500 | 558,823,500 | 558,823,500 | 558,823,500 |
| 资本公积 | 3,607,088,514.33 | 3,607,088,514.33 | 3,607,480,841.6 | 3,607,480,841.6 |
| 减:库存股 | 27,585,916 | - | - | - |
| 盈余公积 | 183,831,416.84 | 183,831,416.84 | 142,463,382.7 | 142,463,382.7 |
| 未分配利润 | 3,281,021,593.55 | 3,082,290,465.23 | 3,000,267,617.1 | 2,868,665,126.97 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,603,179,108.72 | 7,432,033,896.4 | 7,309,035,341.4 | 7,177,432,851.27 |
| 少数股东权益 | 5,532,450.68 | 5,154,892.95 | -2,068,634.2 | -1,265,520.53 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,608,711,559.4 | 7,437,188,789.35 | 7,306,966,707.2 | 7,176,167,330.74 |
| 负债和股东权益合计 | 10,400,762,610.74 | 10,361,635,348.92 | 9,779,405,912.97 | 9,650,952,129.43 |
| 公告日期 | 2024-04-16 | 2024-04-16 | 2023-10-19 | 2023-07-29 |
| 审计意见(境内) | | 标准无保留意见 | | |